Business Description
Omada Health Inc
NAICS : 923120
SIC : 5045
ISIN : US68170A1088
Total Employee Number:
946Description
Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.77 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 11.66 | |||||
Beneish M-Score | -2.14 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 56 | |||||
3-Year EBITDA Growth Rate | 54.1 | |||||
3-Year EPS without NRI Growth Rate | 45.5 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 23.34 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 52.88 | |||||
9-Day RSI | 55.18 | |||||
14-Day RSI | 55.88 | |||||
3-1 Month Momentum % | 31.62 | |||||
6-1 Month Momentum % | 66.36 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.91 | |||||
Quick Ratio | 3.85 | |||||
Cash Ratio | 2.94 | |||||
Days Inventory | 14.11 | |||||
Days Sales Outstanding | 33.19 | |||||
Days Payable | 31.8 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 68.19 | |||||
Operating Margin % | -0.15 | |||||
Net Margin % | 1.39 | |||||
EBITDA Margin % | 3.42 | |||||
FCF Margin % | 5.44 | |||||
OCF Margin % | 7.55 | |||||
ROE % | 1.87 | |||||
ROA % | 1.41 | |||||
ROIC % | -0.72 | |||||
3-Year ROIIC % | 243.92 | |||||
ROC (Joel Greenblatt) % | 59.41 | |||||
ROCE % | 1.99 | |||||
Moat Score | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 485.4 | |||||
Forward PE Ratio | 243.37 | |||||
PE Ratio without NRI | 269.67 | |||||
PS Ratio | 4.69 | |||||
PB Ratio | 5.82 | |||||
Price-to-Tangible-Book | 6.18 | |||||
Price-to-Free-Cash-Flow | 82.55 | |||||
Price-to-Operating-Cash-Flow | 60.07 | |||||
EV-to-EBIT | 274.83 | |||||
EV-to-EBITDA | 121.96 | |||||
EV-to-Forward-EBITDA | 629.59 | |||||
EV-to-Revenue | 4.17 | |||||
EV-to-Forward-Revenue | 3.84 | |||||
EV-to-FCF | 75.45 | |||||
Price-to-Graham-Number | 8.6 | |||||
| Price-to-Net-Current-Asset-Value | 6.71 | |||||
| Price-to-Net-Cash | 10.05 | |||||
Earnings Yield (Greenblatt) % | 0.36 | |||||
FCF Yield % | 1.15 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Omada Health Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 266.487 | ||
| EPS (TTM) (€) | 0.043 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 55.88 | ||
| 14-Day ATR (€) | 0.496268 | ||
| 20-Day SMA (€) | 19.425 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 9.06 - 21.4 | ||
| Shares Outstanding (Mil) | 61.22 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Omada Health Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Omada Health Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-06 16:30 | In 70 days | ||
| Third quarter earnings results for 2026 | 2026-11-06 | In 69 days | ||
| Investor Day | 2026-09-10 13:00 | In 13 days | ||
| Canaccord Genuity’s 46th annual Growth Conference | 2026-08-11 08:00 | 21.00 (+3.96%) | ||
| Second quarter earnings conference call for 2026 | 2026-08-06 16:30 | 17.30 (+0.00%) | ||
| Second quarter earnings results for 2026 | 2026-08-06 | 17.30 (+0.00%) | ||
| General meeting for 2025 | 2026-06-16 09:00 | 14.90 (+0.00%) | ||
| Goldman Sachs 47th Annual Global Healthcare Conference | 2026-06-10 20:20 | 15.20 (+0.00%) | ||
| First quarter earnings conference call for 2026 | 2026-05-07 16:30 | 13.20 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-07 | 13.20 (+0.00%) |
Show
Entries
Omada Health Inc Frequently Asked Questions
What is Omada Health Inc(FRA:U76)'s stock price today?
The current price of FRA:U76 is €20.20. The 52 week high of FRA:U76 is €21.40 and 52 week low is €9.06.
When is next earnings date of Omada Health Inc(FRA:U76)?
The next earnings date of Omada Health Inc(FRA:U76) is 2026-11-06 Est..
Does Omada Health Inc(FRA:U76) pay dividends? If so, how much?
Omada Health Inc(FRA:U76) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Omada Health Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers